Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × pegfilgrastim × 30 days × Clear all

Sponsor

Conditions

Hodgkin Disease 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Lymphoma, AIDS-Related 1 Inflammatory Breast Neoplasms 1 Infiltrating Bladder Urothelial Carcinoma 1 Glioma 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 13 Nivolumab 9 Specimen Handling 8 Gemcitabine 8 Magnetic Resonance Spectroscopy 7 Carboplatin 7 enfortumab vedotin 6 Cisplatin 6 Docetaxel 5 sacituzumab govitecan 4 atezolizumab 4 durvalumab 3 avelumab 3 Taxes 3 Paclitaxel 3 Ipilimumab 3 tislelizumab 2 erdafitinib 2 cabozantinib 2 Radiosurgery 2 Platinum 2 CTLA-4 Antigen 2 zanidatamab 1 veliparib 1 urelumab 1 tremelimumab 1 tazemetostat 1 sapanisertib 1 relatlimab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡